Novel motif:26
From FANTOM5_SSTAR
name: | motif26_CTCCGCAGTA |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0033092 | positive regulation of immature T cell proliferation in thymus | 8.081208e-9 |
GO:0007020 | microtubule nucleation | 8.243200e-9 |
GO:0006264 | mitochondrial DNA replication | 4.731838e-8 |
GO:0072111 | cell proliferation involved in kidney development | 9.683835e-8 |
GO:0032042 | mitochondrial DNA metabolic process | 5.116781e-7 |
GO:0018160 | peptidyl-pyrromethane cofactor linkage | 6.887788e-7 |
GO:0060876 | semicircular canal formation | 1.850970e-6 |
GO:0006756 | AMP phosphorylation | 2.593282e-6 |
GO:0007339 | binding of sperm to zona pellucida | 2.735614e-6 |
GO:0046511 | sphinganine biosynthetic process | 2.894140e-6 |
GO:0015842 | synaptic vesicle amine transport | 2.894140e-6 |
GO:0016180 | snRNA processing | 3.714347e-6 |
GO:0051586 | positive regulation of dopamine uptake | 4.412272e-6 |
GO:0071242 | cellular response to ammonium ion | 4.412272e-6 |
GO:0015742 | alpha-ketoglutarate transport | 5.279485e-6 |
GO:0016073 | snRNA metabolic process | 5.742339e-6 |
GO:0033084 | regulation of immature T cell proliferation in thymus | 5.885276e-6 |
GO:0034470 | ncRNA processing | 6.047431e-6 |
GO:0046512 | sphingosine biosynthetic process | 6.118820e-6 |
GO:0071167 | ribonucleoprotein complex import into nucleus | 6.805043e-6 |
GO:0033574 | response to testosterone stimulus | 7.717257e-6 |
GO:0007634 | optokinetic behavior | 8.498759e-6 |
GO:0021599 | abducens nerve formation | 8.498759e-6 |
GO:0031860 | telomeric 3' overhang formation | 8.618128e-6 |
GO:0060384 | innervation | 9.979005e-6 |
GO:0048752 | semicircular canal morphogenesis | 1.238581e-5 |
GO:0033091 | positive regulation of immature T cell proliferation | 1.242740e-5 |
GO:0016570 | histone modification | 1.260239e-5 |
GO:0006670 | sphingosine metabolic process | 1.651160e-5 |
GO:0035036 | sperm-egg recognition | 1.848614e-5 |
GO:0071732 | cellular response to nitric oxide | 2.014395e-5 |
GO:0071166 | ribonucleoprotein complex localization | 2.502144e-5 |
GO:0042747 | circadian sleep/wake cycle, REM sleep | 2.844150e-5 |
GO:0018107 | peptidyl-threonine phosphorylation | 3.307585e-5 |
GO:0023041 | neuronal signal transduction | 3.549768e-5 |
GO:0060005 | vestibular reflex | 3.555549e-5 |
GO:0046833 | positive regulation of RNA export from nucleus | 3.570086e-5 |
GO:0072203 | cell proliferation involved in metanephros development | 3.624168e-5 |
GO:0016569 | covalent chromatin modification | 4.122869e-5 |
GO:0034660 | ncRNA metabolic process | 4.255747e-5 |
GO:0006667 | sphinganine metabolic process | 4.617419e-5 |
GO:0006408 | snRNA export from nucleus | 4.711994e-5 |
GO:0002041 | intussusceptive angiogenesis | 4.924927e-5 |
GO:0001672 | regulation of chromatin assembly or disassembly | 5.875104e-5 |
GO:0016486 | peptide hormone processing | 5.953200e-5 |
GO:0030573 | bile acid catabolic process | 6.547983e-5 |
GO:0097045 | phosphatidylserine exposure on blood platelet | 6.723005e-5 |
GO:0071072 | negative regulation of phospholipid biosynthetic process | 6.770038e-5 |
GO:2000623 | negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 7.345514e-5 |
GO:0071071 | regulation of phospholipid biosynthetic process | 8.041524e-5 |
GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway | 8.608482e-5 |
GO:0032790 | ribosome disassembly | 9.537194e-5 |
GO:2000340 | positive regulation of chemokine (C-X-C motif) ligand 1 production | 1.049009e-4 |
GO:0061113 | pancreas morphogenesis | 1.049009e-4 |
GO:0035665 | TIRAP-dependent toll-like receptor 4 signaling pathway | 1.049009e-4 |
GO:0032738 | positive regulation of interleukin-15 production | 1.049009e-4 |
GO:0043242 | negative regulation of protein complex disassembly | 1.090890e-4 |
GO:0030488 | tRNA methylation | 1.159611e-4 |
GO:0032074 | negative regulation of nuclease activity | 1.175712e-4 |
GO:0031627 | telomeric loop formation | 1.175712e-4 |
GO:0019227 | neuronal action potential propagation | 1.283164e-4 |
GO:0006768 | biotin metabolic process | 1.438274e-4 |
GO:0016574 | histone ubiquitination | 1.523967e-4 |
GO:0046473 | phosphatidic acid metabolic process | 1.542922e-4 |
GO:0045454 | cell redox homeostasis | 1.567212e-4 |
GO:0050746 | regulation of lipoprotein metabolic process | 1.632561e-4 |
GO:0001510 | RNA methylation | 1.931183e-4 |
GO:0061302 | smooth muscle cell-matrix adhesion | 1.937620e-4 |
GO:0000398 | nuclear mRNA splicing, via spliceosome | 1.945873e-4 |
GO:0019695 | choline metabolic process | 1.961152e-4 |
GO:0000375 | RNA splicing, via transesterification reactions | 2.169918e-4 |
GO:0031114 | regulation of microtubule depolymerization | 2.313034e-4 |
GO:0072303 | positive regulation of glomerular metanephric mesangial cell proliferation | 2.313098e-4 |
GO:0006396 | RNA processing | 2.354844e-4 |
GO:0007026 | negative regulation of microtubule depolymerization | 2.356164e-4 |
GO:0002553 | histamine secretion by mast cell | 2.488864e-4 |
GO:0007402 | ganglion mother cell fate determination | 2.498608e-4 |
GO:0061143 | alveolar primary septum development | 2.499627e-4 |
GO:0001578 | microtubule bundle formation | 2.726480e-4 |
GO:0060430 | lung saccule development | 2.849378e-4 |
GO:0050747 | positive regulation of lipoprotein metabolic process | 2.858051e-4 |
GO:0018393 | internal peptidyl-lysine acetylation | 2.892663e-4 |
GO:0008033 | tRNA processing | 2.945446e-4 |
GO:0032480 | negative regulation of type I interferon production | 2.946468e-4 |
GO:0043456 | regulation of pentose-phosphate shunt | 2.974663e-4 |
GO:0001519 | peptide amidation | 2.974663e-4 |
GO:0046940 | nucleoside monophosphate phosphorylation | 3.041481e-4 |
GO:0015887 | pantothenate transmembrane transport | 3.041481e-4 |
GO:0015878 | biotin transport | 3.041481e-4 |
GO:0001514 | selenocysteine incorporation | 3.155810e-4 |
GO:0034509 | centromeric core chromatin assembly | 3.234426e-4 |
GO:0018394 | peptidyl-lysine acetylation | 3.582177e-4 |
GO:0033083 | regulation of immature T cell proliferation | 3.773256e-4 |
GO:0018210 | peptidyl-threonine modification | 3.849126e-4 |
GO:0090128 | regulation of synapse maturation | 3.926254e-4 |
GO:0070447 | positive regulation of oligodendrocyte progenitor proliferation | 4.451284e-4 |
GO:0010933 | positive regulation of macrophage tolerance induction | 4.951394e-4 |
GO:0097117 | guanylate kinase-associated protein clustering | 4.952414e-4 |
GO:0097112 | gamma-aminobutyric acid receptor clustering | 4.952414e-4 |
GO:0097114 | N-methyl-D-aspartate receptor clustering | 4.952414e-4 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 5.041435e-4 |
GO:0006096 | glycolysis | 5.211057e-4 |
GO:0035771 | interleukin-4-mediated signaling pathway | 5.419733e-4 |
GO:0051589 | negative regulation of neurotransmitter transport | 5.432845e-4 |
GO:0003272 | endocardial cushion formation | 5.607744e-4 |
GO:0048861 | leukemia inhibitory factor signaling pathway | 5.760270e-4 |
GO:0021615 | glossopharyngeal nerve morphogenesis | 5.790764e-4 |
GO:0060447 | bud outgrowth involved in lung branching | 5.790764e-4 |
GO:0006713 | glucocorticoid catabolic process | 6.561660e-4 |
GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity | 6.641810e-4 |
GO:0006475 | internal protein amino acid acetylation | 6.737970e-4 |
GO:0071731 | response to nitric oxide | 6.757256e-4 |
GO:0071353 | cellular response to interleukin-4 | 7.075023e-4 |
GO:0000492 | box C/D snoRNP assembly | 7.180381e-4 |
GO:0031223 | auditory behavior | 7.224803e-4 |
GO:0033590 | response to cobalamin | 7.310712e-4 |
GO:0006117 | acetaldehyde metabolic process | 7.310712e-4 |
GO:0006901 | vesicle coating | 7.381845e-4 |
GO:0016575 | histone deacetylation | 8.070402e-4 |
GO:2000304 | positive regulation of ceramide biosynthetic process | 8.163721e-4 |
GO:0051030 | snRNA transport | 8.747028e-4 |
GO:0032912 | negative regulation of transforming growth factor beta2 production | 8.840143e-4 |
GO:0008209 | androgen metabolic process | 8.975178e-4 |
GO:0002532 | production of molecular mediator involved in inflammatory response | 9.247587e-4 |
GO:0060359 | response to ammonium ion | 9.292557e-4 |
GO:0048168 | regulation of neuronal synaptic plasticity | 9.301877e-4 |
GO:0071585 | detoxification of cadmium ion | 9.429508e-4 |
GO:0060683 | regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling | 9.540086e-4 |
GO:0051643 | endoplasmic reticulum localization | 9.622675e-4 |
GO:0021854 | hypothalamus development | 9.648570e-4 |
GO:0006473 | protein acetylation | 1.012586e-3 |
GO:0060710 | chorio-allantoic fusion | 1.069127e-3 |
GO:0016573 | histone acetylation | 1.114590e-3 |
GO:0043415 | positive regulation of skeletal muscle tissue regeneration | 1.161512e-3 |
GO:0034969 | histone arginine methylation | 1.168560e-3 |
GO:0050909 | sensory perception of taste | 1.179494e-3 |
GO:0035137 | hindlimb morphogenesis | 1.221235e-3 |
GO:0043543 | protein acylation | 1.226715e-3 |
GO:2000824 | negative regulation of androgen receptor activity | 1.227174e-3 |
GO:0008052 | sensory organ boundary specification | 1.227174e-3 |
GO:0090281 | negative regulation of calcium ion import | 1.227800e-3 |
GO:0071584 | negative regulation of zinc ion import | 1.227800e-3 |
GO:0006730 | one-carbon metabolic process | 1.232290e-3 |
GO:0018364 | peptidyl-glutamine methylation | 1.240810e-3 |
GO:0051567 | histone H3-K9 methylation | 1.243763e-3 |
GO:0032241 | positive regulation of nucleobase-containing compound transport | 1.298446e-3 |
GO:0031111 | negative regulation of microtubule polymerization or depolymerization | 1.300940e-3 |
GO:0001941 | postsynaptic membrane organization | 1.311129e-3 |
GO:0033169 | histone H3-K9 demethylation | 1.351688e-3 |
GO:0015855 | pyrimidine base transport | 1.427094e-3 |
GO:0035606 | peptidyl-cysteine S-trans-nitrosylation | 1.472455e-3 |
GO:0010960 | magnesium ion homeostasis | 1.472455e-3 |
GO:0034633 | retinol transport | 1.472455e-3 |
GO:0030540 | female genitalia development | 1.485385e-3 |
GO:0016567 | protein ubiquitination | 1.493522e-3 |
GO:0048167 | regulation of synaptic plasticity | 1.499102e-3 |
GO:2000303 | regulation of ceramide biosynthetic process | 1.534138e-3 |
GO:0072126 | positive regulation of glomerular mesangial cell proliferation | 1.534138e-3 |
GO:0071506 | cellular response to mycophenolic acid | 1.534138e-3 |
GO:0097120 | receptor localization to synapse | 1.586375e-3 |
GO:0072578 | neurotransmitter-gated ion channel clustering | 1.586375e-3 |
GO:0006261 | DNA-dependent DNA replication | 1.601594e-3 |
GO:0010983 | positive regulation of high-density lipoprotein particle clearance | 1.802266e-3 |
GO:0048103 | somatic stem cell division | 1.850762e-3 |
GO:0006415 | translational termination | 1.864433e-3 |
GO:0003198 | epithelial to mesenchymal transition involved in endocardial cushion formation | 1.876535e-3 |
GO:0090331 | negative regulation of platelet aggregation | 1.885495e-3 |
GO:0061110 | dense core granule biogenesis | 1.885495e-3 |
GO:0061108 | seminal vesicle epithelium development | 1.885495e-3 |
GO:0042628 | mating plug formation | 1.885495e-3 |
GO:0021610 | facial nerve morphogenesis | 1.891357e-3 |
GO:0019276 | UDP-N-acetylgalactosamine metabolic process | 2.050927e-3 |
GO:0018198 | peptidyl-cysteine modification | 2.084735e-3 |
GO:0060033 | anatomical structure regression | 2.086329e-3 |
GO:0021960 | anterior commissure morphogenesis | 2.156293e-3 |
GO:0021754 | facial nucleus development | 2.161530e-3 |
GO:0018205 | peptidyl-lysine modification | 2.166641e-3 |
GO:0003278 | apoptosis involved in heart morphogenesis | 2.185304e-3 |
GO:0032259 | methylation | 2.214355e-3 |
GO:0046952 | ketone body catabolic process | 2.241134e-3 |
GO:0060947 | cardiac vascular smooth muscle cell differentiation | 2.241134e-3 |
GO:0006882 | cellular zinc ion homeostasis | 2.272794e-3 |
GO:0034373 | intermediate-density lipoprotein particle remodeling | 2.273909e-3 |
GO:0051257 | spindle midzone assembly involved in meiosis | 2.305814e-3 |
GO:0010727 | negative regulation of hydrogen peroxide metabolic process | 2.305814e-3 |
GO:0007060 | male meiosis chromosome segregation | 2.305814e-3 |
GO:0043624 | cellular protein complex disassembly | 2.434695e-3 |
GO:0006007 | glucose catabolic process | 2.524447e-3 |
GO:0034766 | negative regulation of ion transmembrane transport | 2.551324e-3 |
GO:0035048 | splicing factor protein import into nucleus | 2.551324e-3 |
GO:0006471 | protein ADP-ribosylation | 2.551544e-3 |
GO:0048280 | vesicle fusion with Golgi apparatus | 2.613863e-3 |
GO:0030851 | granulocyte differentiation | 2.668942e-3 |
GO:0034638 | phosphatidylcholine catabolic process | 2.681200e-3 |
GO:0006546 | glycine catabolic process | 2.723852e-3 |
GO:0007625 | grooming behavior | 2.733891e-3 |
GO:0000387 | spliceosomal snRNP assembly | 2.824954e-3 |
GO:0007052 | mitotic spindle organization | 2.902057e-3 |
GO:0070670 | response to interleukin-4 | 2.909607e-3 |
GO:0071394 | cellular response to testosterone stimulus | 2.987954e-3 |
GO:0060510 | Type II pneumocyte differentiation | 3.048435e-3 |
GO:0031125 | rRNA 3'-end processing | 3.111332e-3 |
GO:0021979 | hypothalamus cell differentiation | 3.136850e-3 |
GO:0051891 | positive regulation of cardioblast differentiation | 3.173684e-3 |
GO:0021561 | facial nerve development | 3.265051e-3 |
GO:0060916 | mesenchymal cell proliferation involved in lung development | 3.269771e-3 |
GO:0009069 | serine family amino acid metabolic process | 3.279184e-3 |
GO:0006742 | NADP catabolic process | 3.329202e-3 |
GO:0007623 | circadian rhythm | 3.357540e-3 |
GO:0090305 | nucleic acid phosphodiester bond hydrolysis | 3.387005e-3 |
GO:0043241 | protein complex disassembly | 3.404552e-3 |
GO:0016446 | somatic hypermutation of immunoglobulin genes | 3.480329e-3 |
GO:0070213 | protein auto-ADP-ribosylation | 3.500648e-3 |
GO:0070212 | protein poly-ADP-ribosylation | 3.507221e-3 |
GO:0035461 | vitamin transmembrane transport | 3.578349e-3 |
GO:0021997 | neural plate axis specification | 3.578349e-3 |
GO:0051665 | membrane raft localization | 3.619412e-3 |
GO:0006900 | membrane budding | 3.692794e-3 |
GO:0009071 | serine family amino acid catabolic process | 3.725268e-3 |
GO:0048808 | male genitalia morphogenesis | 3.748810e-3 |
GO:0090129 | positive regulation of synapse maturation | 3.812360e-3 |
GO:0008105 | asymmetric protein localization | 3.871172e-3 |
GO:0001829 | trophectodermal cell differentiation | 3.938705e-3 |
GO:0010512 | negative regulation of phosphatidylinositol biosynthetic process | 3.976995e-3 |
GO:0060561 | apoptosis involved in morphogenesis | 4.156811e-3 |
GO:0071460 | cellular response to cell-matrix adhesion | 4.231132e-3 |
GO:0003181 | atrioventricular valve morphogenesis | 4.354055e-3 |
GO:0050913 | sensory perception of bitter taste | 4.354055e-3 |
GO:0060738 | epithelial-mesenchymal signaling involved in prostate gland development | 4.405670e-3 |
GO:0021636 | trigeminal nerve morphogenesis | 4.405670e-3 |
GO:0021569 | rhombomere 3 development | 4.405670e-3 |
GO:0008050 | female courtship behavior | 4.423484e-3 |
GO:0010157 | response to chlorate | 4.456054e-3 |
GO:0070106 | interleukin-27-mediated signaling pathway | 4.495563e-3 |
GO:0032911 | negative regulation of transforming growth factor beta1 production | 4.495563e-3 |
GO:0010511 | regulation of phosphatidylinositol biosynthetic process | 4.495563e-3 |
GO:0015820 | leucine transport | 4.495563e-3 |
GO:0030262 | apoptotic nuclear change | 4.512954e-3 |
GO:0008228 | opsonization | 4.619730e-3 |
GO:0018924 | mandelate metabolic process | 4.684079e-3 |
GO:0060872 | semicircular canal development | 4.692701e-3 |
GO:0021793 | chemorepulsion of branchiomotor axon | 4.788624e-3 |
GO:0009635 | response to herbicide | 4.818148e-3 |
GO:0060689 | cell differentiation involved in salivary gland development | 4.891807e-3 |
GO:0071895 | odontoblast differentiation | 4.923539e-3 |
GO:0014813 | satellite cell commitment | 4.948666e-3 |
GO:0051588 | regulation of neurotransmitter transport | 4.994510e-3 |
GO:0006436 | tryptophanyl-tRNA aminoacylation | 5.066366e-3 |
GO:0032988 | ribonucleoprotein complex disassembly | 5.077739e-3 |
GO:0060396 | growth hormone receptor signaling pathway | 5.081412e-3 |
GO:0021675 | nerve development | 5.099834e-3 |
GO:2000062 | negative regulation of ureter smooth muscle cell differentiation | 5.202039e-3 |
GO:2000063 | positive regulation of ureter smooth muscle cell differentiation | 5.202039e-3 |
GO:2000729 | positive regulation of mesenchymal cell proliferation involved in ureter development | 5.202039e-3 |
GO:2000358 | positive regulation of kidney smooth muscle cell differentiation | 5.202039e-3 |
GO:2000357 | negative regulation of kidney smooth muscle cell differentiation | 5.202039e-3 |
GO:0060783 | mesenchymal smoothened signaling pathway involved in prostate gland development | 5.202039e-3 |
GO:0007502 | digestive tract mesoderm development | 5.202039e-3 |
GO:0080125 | multicellular structure septum development | 5.202039e-3 |
GO:0014858 | positive regulation of skeletal muscle cell proliferation | 5.202039e-3 |
GO:0046534 | positive regulation of photoreceptor cell differentiation | 5.202039e-3 |
GO:0060782 | regulation of mesenchymal cell proliferation involved in prostate gland development | 5.202039e-3 |
GO:0097118 | neuroligin clustering | 5.204033e-3 |
GO:0034445 | negative regulation of plasma lipoprotein particle oxidation | 5.245104e-3 |
GO:0035601 | protein deacylation | 5.249636e-3 |
GO:0000160 | two-component signal transduction system (phosphorelay) | 5.275915e-3 |
GO:0017145 | stem cell division | 5.297128e-3 |
GO:0060713 | labyrinthine layer morphogenesis | 5.453270e-3 |
GO:0030513 | positive regulation of BMP signaling pathway | 5.465222e-3 |
GO:0009988 | cell-cell recognition | 5.467344e-3 |
GO:0043266 | regulation of potassium ion transport | 5.568248e-3 |
GO:0032446 | protein modification by small protein conjugation | 5.594465e-3 |
GO:0051650 | establishment of vesicle localization | 5.634043e-3 |
GO:0007621 | negative regulation of female receptivity | 5.692940e-3 |
GO:0043244 | regulation of protein complex disassembly | 5.830203e-3 |
GO:0071864 | positive regulation of cell proliferation in bone marrow | 5.926779e-3 |
GO:0071866 | negative regulation of apoptosis in bone marrow | 5.926779e-3 |
GO:0046836 | glycolipid transport | 5.926779e-3 |
GO:0010544 | negative regulation of platelet activation | 5.939596e-3 |
GO:0008057 | eye pigment granule organization | 5.939780e-3 |
GO:0018193 | peptidyl-amino acid modification | 5.986644e-3 |
GO:0021784 | postganglionic parasympathetic nervous system development | 6.080984e-3 |
GO:0006006 | glucose metabolic process | 6.125637e-3 |
GO:0015793 | glycerol transport | 6.259615e-3 |
GO:0021985 | neurohypophysis development | 6.269087e-3 |
GO:0003184 | pulmonary valve morphogenesis | 6.269087e-3 |
GO:0006476 | protein deacetylation | 6.317332e-3 |
GO:0070988 | demethylation | 6.381278e-3 |
GO:0046500 | S-adenosylmethionine metabolic process | 6.392325e-3 |
GO:0008589 | regulation of smoothened signaling pathway | 6.485285e-3 |
GO:0006525 | arginine metabolic process | 6.491074e-3 |
GO:0032479 | regulation of type I interferon production | 6.536284e-3 |
GO:0033233 | regulation of protein sumoylation | 6.586646e-3 |
GO:0051131 | chaperone-mediated protein complex assembly | 6.613682e-3 |
GO:0071398 | cellular response to fatty acid | 6.732690e-3 |
GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste | 6.767152e-3 |
GO:2000096 | positive regulation of Wnt receptor signaling pathway, planar cell polarity pathway | 6.773200e-3 |
GO:0001825 | blastocyst formation | 6.873843e-3 |
GO:0030916 | otic vesicle formation | 6.957179e-3 |
GO:0034623 | cellular macromolecular complex disassembly | 7.050048e-3 |
GO:0042297 | vocal learning | 7.068158e-3 |
GO:0072110 | glomerular mesangial cell proliferation | 7.127959e-3 |
GO:0045943 | positive regulation of transcription from RNA polymerase I promoter | 7.127959e-3 |
GO:0010882 | regulation of cardiac muscle contraction by calcium ion signaling | 7.154502e-3 |
GO:0009914 | hormone transport | 7.216954e-3 |
GO:0060486 | Clara cell differentiation | 7.280301e-3 |
GO:0018119 | peptidyl-cysteine S-nitrosylation | 7.356489e-3 |
GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process | 7.726066e-3 |
GO:0000724 | double-strand break repair via homologous recombination | 7.747297e-3 |
GO:2000104 | negative regulation of DNA-dependent DNA replication | 7.805040e-3 |
GO:0072526 | pyridine-containing compound catabolic process | 7.846020e-3 |
GO:0010986 | positive regulation of lipoprotein particle clearance | 7.846020e-3 |
GO:0019853 | L-ascorbic acid biosynthetic process | 7.846020e-3 |
GO:0071843 | cellular component biogenesis at cellular level | 7.997213e-3 |
GO:0071474 | cellular hyperosmotic response | 8.171478e-3 |
GO:0061205 | paramesonephric duct development | 8.171478e-3 |
GO:0060428 | lung epithelium development | 8.302049e-3 |
GO:0007638 | mechanosensory behavior | 8.319864e-3 |
GO:0045626 | negative regulation of T-helper 1 cell differentiation | 8.388162e-3 |
GO:0043628 | ncRNA 3'-end processing | 8.388162e-3 |
GO:0042752 | regulation of circadian rhythm | 8.396083e-3 |
GO:0042254 | ribosome biogenesis | 8.417581e-3 |
GO:0070934 | CRD-mediated mRNA stabilization | 8.429793e-3 |
GO:0006207 | 'de novo' pyrimidine base biosynthetic process | 8.429793e-3 |
GO:0006281 | DNA repair | 8.436643e-3 |
GO:0031109 | microtubule polymerization or depolymerization | 8.586039e-3 |
GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity | 8.825400e-3 |
GO:0071845 | cellular component disassembly at cellular level | 8.844530e-3 |
GO:0071625 | vocalization behavior | 9.024161e-3 |
GO:0001824 | blastocyst development | 9.030677e-3 |
GO:0032984 | macromolecular complex disassembly | 9.059715e-3 |
GO:0006369 | termination of RNA polymerase II transcription | 9.106228e-3 |
GO:0070059 | apoptosis in response to endoplasmic reticulum stress | 9.117628e-3 |
GO:0030223 | neutrophil differentiation | 9.130666e-3 |
GO:0051590 | positive regulation of neurotransmitter transport | 9.139270e-3 |
GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway | 9.174350e-3 |
GO:0031118 | rRNA pseudouridine synthesis | 9.174350e-3 |
GO:0000725 | recombinational repair | 9.296995e-3 |
GO:0042177 | negative regulation of protein catabolic process | 9.341499e-3 |
GO:0045950 | negative regulation of mitotic recombination | 9.398900e-3 |
GO:0002543 | activation of blood coagulation via clotting cascade | 9.398900e-3 |
GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan | 9.406929e-3 |
GO:0006741 | NADP biosynthetic process | 9.598072e-3 |
GO:0035732 | nitric oxide storage | 9.598072e-3 |
GO:0071638 | negative regulation of monocyte chemotactic protein-1 production | 9.598072e-3 |
GO:0035726 | common myeloid progenitor cell proliferation | 9.598072e-3 |
GO:0060684 | epithelial-mesenchymal cell signaling | 9.626644e-3 |
GO:0035518 | histone H2A monoubiquitination | 9.626644e-3 |
GO:0003197 | endocardial cushion development | 9.703948e-3 |
GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter | 9.791548e-3 |
GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity | 9.825341e-3 |
GO:0051890 | regulation of cardioblast differentiation | 9.932668e-3 |
GO:0097091 | synaptic vesicle clustering | 9.988098e-3 |
GO:0006103 | 2-oxoglutarate metabolic process | 1.000733e-2 |
GO:0000226 | microtubule cytoskeleton organization | 1.019122e-2 |
GO:0050965 | detection of temperature stimulus involved in sensory perception of pain | 1.023491e-2 |
GO:0007091 | mitotic metaphase/anaphase transition | 1.027581e-2 |
GO:0006544 | glycine metabolic process | 1.028866e-2 |
GO:0022411 | cellular component disassembly | 1.033199e-2 |
GO:0072180 | mesonephric duct morphogenesis | 1.035347e-2 |
GO:0031558 | induction of apoptosis in response to chemical stimulus | 1.057385e-2 |
GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly | 1.059189e-2 |
GO:0035229 | positive regulation of glutamate-cysteine ligase activity | 1.059189e-2 |
GO:0043060 | meiotic metaphase I plate congression | 1.059189e-2 |
GO:0016539 | intein-mediated protein splicing | 1.075837e-2 |
GO:0021570 | rhombomere 4 development | 1.075837e-2 |
GO:0003140 | determination of left/right asymmetry in lateral mesoderm | 1.075837e-2 |
GO:0048859 | formation of anatomical boundary | 1.083109e-2 |
GO:0007529 | establishment of synaptic specificity at neuromuscular junction | 1.083109e-2 |
GO:2000463 | positive regulation of excitatory postsynaptic membrane potential | 1.101081e-2 |
GO:0048205 | COPI coating of Golgi vesicle | 1.152061e-2 |
GO:0046112 | nucleobase biosynthetic process | 1.165443e-2 |
GO:0043503 | skeletal muscle fiber adaptation | 1.195299e-2 |
GO:0014911 | positive regulation of smooth muscle cell migration | 1.198454e-2 |
GO:0097116 | gephyrin clustering | 1.199819e-2 |
GO:0032355 | response to estradiol stimulus | 1.205876e-2 |
GO:0000154 | rRNA modification | 1.205977e-2 |
GO:0035279 | mRNA cleavage involved in gene silencing by miRNA | 1.205977e-2 |
GO:0048368 | lateral mesoderm development | 1.213181e-2 |
GO:0001878 | response to yeast | 1.222360e-2 |
GO:0007619 | courtship behavior | 1.225780e-2 |
GO:0015696 | ammonium transport | 1.230835e-2 |
GO:0030104 | water homeostasis | 1.231937e-2 |
GO:0015804 | neutral amino acid transport | 1.241895e-2 |
GO:0033522 | histone H2A ubiquitination | 1.258001e-2 |
GO:0045799 | positive regulation of chromatin assembly or disassembly | 1.271640e-2 |
GO:0070781 | response to biotin | 1.271640e-2 |
GO:0035545 | determination of left/right asymmetry in nervous system | 1.271640e-2 |
GO:0051584 | regulation of dopamine uptake | 1.273896e-2 |
GO:0072301 | regulation of metanephric glomerular mesangial cell proliferation | 1.281407e-2 |
GO:0072136 | metanephric mesenchymal cell proliferation involved in metanephros development | 1.281407e-2 |
GO:0055069 | zinc ion homeostasis | 1.307759e-2 |
GO:0003009 | skeletal muscle contraction | 1.347157e-2 |
GO:0031629 | synaptic vesicle fusion to presynaptic membrane | 1.348992e-2 |
GO:0051531 | NFAT protein import into nucleus | 1.373224e-2 |
GO:0048069 | eye pigmentation | 1.389237e-2 |
GO:0060629 | regulation of homologous chromosome segregation | 1.393447e-2 |
GO:0051598 | meiotic recombination checkpoint | 1.393447e-2 |
GO:0006948 | induction by virus of host cell-cell fusion | 1.393447e-2 |
GO:0045234 | protein palmitoleylation | 1.393447e-2 |
GO:0010817 | regulation of hormone levels | 1.393614e-2 |
GO:0014909 | smooth muscle cell migration | 1.419759e-2 |
GO:0043278 | response to morphine | 1.423251e-2 |
GO:0035793 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway | 1.445958e-2 |
GO:0046165 | alcohol biosynthetic process | 1.459312e-2 |
GO:0002355 | detection of tumor cell | 1.484895e-2 |
GO:0006364 | rRNA processing | 1.487619e-2 |
GO:0034776 | response to histamine | 1.496806e-2 |
GO:0046879 | hormone secretion | 1.503194e-2 |
GO:0032674 | regulation of interleukin-5 production | 1.508003e-2 |
GO:0016048 | detection of temperature stimulus | 1.509793e-2 |
GO:0006289 | nucleotide-excision repair | 1.525162e-2 |
GO:0048169 | regulation of long-term neuronal synaptic plasticity | 1.528936e-2 |
GO:0043271 | negative regulation of ion transport | 1.568899e-2 |
GO:0010002 | cardioblast differentiation | 1.568964e-2 |
GO:0032902 | nerve growth factor production | 1.570764e-2 |
GO:0045924 | regulation of female receptivity | 1.585213e-2 |
GO:0021683 | cerebellar granular layer morphogenesis | 1.589292e-2 |
GO:0048199 | vesicle targeting, to, from or within Golgi | 1.607598e-2 |
GO:0006308 | DNA catabolic process | 1.628883e-2 |
GO:0033314 | mitotic cell cycle DNA replication checkpoint | 1.641278e-2 |
GO:0006012 | galactose metabolic process | 1.649952e-2 |
GO:0031110 | regulation of microtubule polymerization or depolymerization | 1.658837e-2 |
GO:0010224 | response to UV-B | 1.663802e-2 |
GO:0051851 | modification by host of symbiont morphology or physiology | 1.667716e-2 |
GO:0021602 | cranial nerve morphogenesis | 1.689606e-2 |
GO:0051668 | localization within membrane | 1.698552e-2 |
GO:0045063 | T-helper 1 cell differentiation | 1.709013e-2 |
GO:0070849 | response to epidermal growth factor stimulus | 1.718873e-2 |
GO:0097119 | postsynaptic density protein 95 clustering | 1.727815e-2 |
GO:0097104 | postsynaptic membrane assembly | 1.727815e-2 |
GO:0046449 | creatinine metabolic process | 1.729493e-2 |
GO:0043985 | histone H4-R3 methylation | 1.729493e-2 |
GO:0072109 | glomerular mesangium development | 1.734270e-2 |
GO:0048352 | paraxial mesoderm structural organization | 1.736826e-2 |
GO:0021998 | neural plate mediolateral regionalization | 1.736826e-2 |
GO:0001539 | ciliary or flagellar motility | 1.752952e-2 |
GO:0007379 | segment specification | 1.755843e-2 |
GO:0043603 | cellular amide metabolic process | 1.758199e-2 |
GO:0043923 | positive regulation by host of viral transcription | 1.760839e-2 |
GO:0048009 | insulin-like growth factor receptor signaling pathway | 1.762882e-2 |
GO:0014040 | positive regulation of Schwann cell differentiation | 1.767322e-2 |
GO:0007228 | positive regulation of hh target transcription factor activity | 1.767322e-2 |
GO:0090197 | positive regulation of chemokine secretion | 1.769522e-2 |
GO:0002686 | negative regulation of leukocyte migration | 1.794036e-2 |
GO:0006526 | arginine biosynthetic process | 1.806748e-2 |
GO:0051926 | negative regulation of calcium ion transport | 1.818191e-2 |
GO:0030210 | heparin biosynthetic process | 1.893515e-2 |
GO:0048194 | Golgi vesicle budding | 1.907785e-2 |
GO:0022613 | ribonucleoprotein complex biogenesis | 1.925421e-2 |
GO:0034144 | negative regulation of toll-like receptor 4 signaling pathway | 1.930320e-2 |
GO:0097105 | presynaptic membrane assembly | 1.940740e-2 |
GO:0060631 | regulation of meiosis I | 1.980903e-2 |
GO:0000422 | mitochondrion degradation | 1.980903e-2 |
GO:0090042 | tubulin deacetylation | 1.984569e-2 |
GO:0070846 | Hsp90 deacetylation | 1.984569e-2 |
GO:0043012 | regulation of fusion of sperm to egg plasma membrane | 1.984569e-2 |
GO:0051261 | protein depolymerization | 2.011394e-2 |
GO:0019083 | viral transcription | 2.021727e-2 |
GO:0015939 | pantothenate metabolic process | 2.036209e-2 |
GO:0060056 | mammary gland involution | 2.038647e-2 |
GO:0046340 | diacylglycerol catabolic process | 2.046586e-2 |
GO:0006382 | adenosine to inosine editing | 2.065950e-2 |
GO:2000119 | negative regulation of sodium-dependent phosphate transport | 2.071616e-2 |
GO:2000016 | negative regulation of determination of dorsal identity | 2.071616e-2 |
GO:0071599 | otic vesicle development | 2.078590e-2 |
GO:0034375 | high-density lipoprotein particle remodeling | 2.078590e-2 |
GO:0034143 | regulation of toll-like receptor 4 signaling pathway | 2.084784e-2 |
GO:0032876 | negative regulation of DNA endoreduplication | 2.091783e-2 |
GO:0010459 | negative regulation of heart rate | 2.115960e-2 |
GO:0006644 | phospholipid metabolic process | 2.151458e-2 |
GO:0045656 | negative regulation of monocyte differentiation | 2.156191e-2 |
GO:0034137 | positive regulation of toll-like receptor 2 signaling pathway | 2.156191e-2 |
GO:0022616 | DNA strand elongation | 2.168277e-2 |
GO:0032212 | positive regulation of telomere maintenance via telomerase | 2.176697e-2 |
GO:0032715 | negative regulation of interleukin-6 production | 2.195499e-2 |
GO:0016072 | rRNA metabolic process | 2.213444e-2 |
GO:0022408 | negative regulation of cell-cell adhesion | 2.223385e-2 |
GO:0014910 | regulation of smooth muscle cell migration | 2.253596e-2 |
GO:0042797 | tRNA transcription from RNA polymerase III promoter | 2.283656e-2 |
GO:0042791 | 5S class rRNA transcription from RNA polymerase III type 1 promoter | 2.283656e-2 |
GO:0019087 | transformation of host cell by virus | 2.295389e-2 |
GO:0034442 | regulation of lipoprotein oxidation | 2.314540e-2 |
GO:0002121 | inter-male aggressive behavior | 2.314540e-2 |
GO:0061188 | negative regulation of chromatin silencing at rDNA | 2.314540e-2 |
GO:0001826 | inner cell mass cell differentiation | 2.314540e-2 |
GO:0002115 | store-operated calcium entry | 2.314540e-2 |
GO:0048268 | clathrin coat assembly | 2.314930e-2 |
GO:0046929 | negative regulation of neurotransmitter secretion | 2.325409e-2 |
GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly | 2.325409e-2 |
GO:0060690 | epithelial cell differentiation involved in salivary gland development | 2.325409e-2 |
GO:0015862 | uridine transport | 2.325409e-2 |
GO:0016559 | peroxisome fission | 2.325409e-2 |
GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation | 2.325409e-2 |
GO:0043414 | macromolecule methylation | 2.326114e-2 |
GO:0002027 | regulation of heart rate | 2.339559e-2 |
GO:0021943 | formation of radial glial scaffolds | 2.351826e-2 |
GO:0009225 | nucleotide-sugar metabolic process | 2.358054e-2 |
GO:0042759 | long-chain fatty acid biosynthetic process | 2.429549e-2 |
GO:0060458 | right lung development | 2.436147e-2 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0047496 | vesicle transport along microtubule | 3.099749e-8 |
GO:0043653 | mitochondrial fragmentation involved in apoptosis | 2.590532e-7 |
GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity | 1.043910e-6 |
GO:0045358 | negative regulation of interferon-beta biosynthetic process | 1.388913e-6 |
GO:0032218 | riboflavin transport | 4.095074e-6 |
GO:0042703 | menstruation | 5.188473e-6 |
GO:0019101 | female somatic sex determination | 5.188473e-6 |
GO:0018293 | protein-FAD linkage | 5.188473e-6 |
GO:0006121 | mitochondrial electron transport, succinate to ubiquinone | 5.188473e-6 |
GO:0045056 | transcytosis | 5.683073e-6 |
GO:0010902 | positive regulation of very-low-density lipoprotein particle remodeling | 5.962471e-6 |
GO:0002829 | negative regulation of type 2 immune response | 9.692476e-6 |
GO:0000910 | cytokinesis | 1.005176e-5 |
GO:0000059 | protein import into nucleus, docking | 1.453821e-5 |
GO:0032908 | regulation of transforming growth factor beta1 production | 1.603917e-5 |
GO:0015780 | nucleotide-sugar transport | 1.991488e-5 |
GO:0032911 | negative regulation of transforming growth factor beta1 production | 2.146594e-5 |
GO:0051044 | positive regulation of membrane protein ectodomain proteolysis | 2.539435e-5 |
GO:0000189 | MAPK import into nucleus | 2.731424e-5 |
GO:0006346 | methylation-dependent chromatin silencing | 2.825896e-5 |
GO:0002485 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent | 3.117537e-5 |
GO:0051775 | response to redox state | 3.395062e-5 |
GO:0080164 | regulation of nitric oxide metabolic process | 3.562248e-5 |
GO:0008366 | axon ensheathment | 3.579474e-5 |
GO:0042552 | myelination | 4.149058e-5 |
GO:0016557 | peroxisome membrane biogenesis | 4.397261e-5 |
GO:0003093 | regulation of glomerular filtration | 4.739584e-5 |
GO:0031577 | spindle checkpoint | 5.803801e-5 |
GO:0071635 | negative regulation of transforming growth factor beta production | 6.292972e-5 |
GO:0050748 | negative regulation of lipoprotein metabolic process | 6.702867e-5 |
GO:0018065 | protein-cofactor linkage | 6.831187e-5 |
GO:0071539 | protein localization to centrosome | 6.977727e-5 |
GO:0002355 | detection of tumor cell | 6.977727e-5 |
GO:0090231 | regulation of spindle checkpoint | 7.080574e-5 |
GO:0006982 | response to lipid hydroperoxide | 1.003614e-4 |
GO:0072384 | organelle transport along microtubule | 1.026151e-4 |
GO:0060347 | heart trabecula formation | 1.104841e-4 |
GO:0042228 | interleukin-8 biosynthetic process | 1.262521e-4 |
GO:0072355 | histone H3-T3 phosphorylation | 1.262521e-4 |
GO:0019858 | cytosine metabolic process | 1.262521e-4 |
GO:0019428 | allantoin biosynthetic process | 1.262521e-4 |
GO:0009637 | response to blue light | 1.262521e-4 |
GO:0055090 | acylglycerol homeostasis | 1.270469e-4 |
GO:0010424 | DNA methylation on cytosine within a CG sequence | 1.272639e-4 |
GO:0045299 | otolith mineralization | 1.303873e-4 |
GO:0050689 | negative regulation of defense response to virus by host | 1.303873e-4 |
GO:0048251 | elastic fiber assembly | 1.445119e-4 |
GO:0032776 | DNA methylation on cytosine | 1.449403e-4 |
GO:0048294 | negative regulation of isotype switching to IgE isotypes | 1.493116e-4 |
GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint | 1.506944e-4 |
GO:0010569 | regulation of double-strand break repair via homologous recombination | 1.532282e-4 |
GO:2000309 | positive regulation of tumor necrosis factor (ligand) superfamily member 11 production | 1.591480e-4 |
GO:0043380 | regulation of memory T cell differentiation | 1.633272e-4 |
GO:0045629 | negative regulation of T-helper 2 cell differentiation | 1.779830e-4 |
GO:0048293 | regulation of isotype switching to IgE isotypes | 1.784588e-4 |
GO:0034379 | very-low-density lipoprotein particle assembly | 1.810184e-4 |
GO:0045046 | protein import into peroxisome membrane | 2.154267e-4 |
GO:0018993 | somatic sex determination | 2.262663e-4 |
GO:0010999 | regulation of eIF2 alpha phosphorylation by heme | 2.262663e-4 |
GO:0009589 | detection of UV | 2.262663e-4 |
GO:0046499 | S-adenosylmethioninamine metabolic process | 2.282972e-4 |
GO:0030237 | female sex determination | 2.430422e-4 |
GO:0071594 | thymocyte aggregation | 2.658945e-4 |
GO:0085029 | extracellular matrix assembly | 2.685705e-4 |
GO:0016574 | histone ubiquitination | 2.703652e-4 |
GO:0017156 | calcium ion-dependent exocytosis | 2.747701e-4 |
GO:0044240 | multicellular organismal lipid catabolic process | 2.824147e-4 |
GO:2000466 | negative regulation of glycogen (starch) synthase activity | 3.012945e-4 |
GO:0002860 | positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 3.125782e-4 |
GO:0001977 | renal system process involved in regulation of blood volume | 3.455134e-4 |
GO:0010390 | histone monoubiquitination | 3.869381e-4 |
GO:0032764 | negative regulation of mast cell cytokine production | 4.063161e-4 |
GO:0015670 | carbon dioxide transport | 4.063161e-4 |
GO:0002858 | regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 4.202066e-4 |
GO:0042335 | cuticle development | 4.611690e-4 |
GO:0043048 | dolichyl monophosphate biosynthetic process | 4.611690e-4 |
GO:0009082 | branched chain family amino acid biosynthetic process | 5.005029e-4 |
GO:0043697 | cell dedifferentiation | 5.157799e-4 |
GO:0001553 | luteinization | 5.314940e-4 |
GO:0016567 | protein ubiquitination | 5.524864e-4 |
GO:0007028 | cytoplasm organization | 5.653617e-4 |
GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway | 5.764116e-4 |
GO:0006342 | chromatin silencing | 6.460010e-4 |
GO:0000226 | microtubule cytoskeleton organization | 6.550236e-4 |
GO:0034969 | histone arginine methylation | 7.162208e-4 |
GO:0042713 | sperm ejaculation | 7.375726e-4 |
GO:0002227 | innate immune response in mucosa | 7.862783e-4 |
GO:0010881 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion | 8.262742e-4 |
GO:0007017 | microtubule-based process | 8.304810e-4 |
GO:0000255 | allantoin metabolic process | 8.523483e-4 |
GO:0046853 | inositol or phosphatidylinositol phosphorylation | 8.620660e-4 |
GO:0010157 | response to chlorate | 8.620660e-4 |
GO:0008057 | eye pigment granule organization | 8.620660e-4 |
GO:0035634 | response to stilbenoid | 9.347134e-4 |
GO:0043526 | neuroprotection | 9.829676e-4 |
GO:0022010 | central nervous system myelination | 1.025508e-3 |
GO:0060829 | negative regulation of canonical Wnt receptor signaling pathway involved in neural plate anterior/posterior pattern formation | 1.030220e-3 |
GO:0006666 | 3-keto-sphinganine metabolic process | 1.030220e-3 |
GO:0008054 | cyclin catabolic process | 1.075484e-3 |
GO:0009994 | oocyte differentiation | 1.094581e-3 |
GO:0032912 | negative regulation of transforming growth factor beta2 production | 1.111383e-3 |
GO:0048599 | oocyte development | 1.156608e-3 |
GO:0006929 | substrate-dependent cell migration | 1.162236e-3 |
GO:0065005 | protein-lipid complex assembly | 1.182396e-3 |
GO:0034445 | negative regulation of plasma lipoprotein particle oxidation | 1.250457e-3 |
GO:0015693 | magnesium ion transport | 1.250457e-3 |
GO:0070934 | CRD-mediated mRNA stabilization | 1.287250e-3 |
GO:0055075 | potassium ion homeostasis | 1.287250e-3 |
GO:0010898 | positive regulation of triglyceride catabolic process | 1.323215e-3 |
GO:0021997 | neural plate axis specification | 1.327376e-3 |
GO:0010970 | microtubule-based transport | 1.351059e-3 |
GO:0045910 | negative regulation of DNA recombination | 1.358988e-3 |
GO:0006710 | androgen catabolic process | 1.371819e-3 |
GO:0032446 | protein modification by small protein conjugation | 1.397955e-3 |
GO:0006513 | protein monoubiquitination | 1.408738e-3 |
GO:0006107 | oxaloacetate metabolic process | 1.494920e-3 |
GO:0002074 | extraocular skeletal muscle development | 1.578142e-3 |
GO:0071459 | protein localization to chromosome, centromeric region | 1.578142e-3 |
GO:0048008 | platelet-derived growth factor receptor signaling pathway | 1.588893e-3 |
GO:0061384 | heart trabecular morphogenesis | 1.623312e-3 |
GO:0043330 | response to exogenous dsRNA | 1.623312e-3 |
GO:0042908 | xenobiotic transport | 1.658319e-3 |
GO:0007030 | Golgi organization | 1.662455e-3 |
GO:0032660 | regulation of interleukin-17 production | 1.696814e-3 |
GO:0051006 | positive regulation of lipoprotein lipase activity | 1.731519e-3 |
GO:0060262 | negative regulation of N-terminal protein palmitoylation | 1.737809e-3 |
GO:0048213 | Golgi vesicle prefusion complex stabilization | 1.737809e-3 |
GO:0060983 | epicardium-derived cardiac vascular smooth muscle cell differentiation | 1.749881e-3 |
GO:0000018 | regulation of DNA recombination | 1.783501e-3 |
GO:0035518 | histone H2A monoubiquitination | 1.799636e-3 |
GO:0032507 | maintenance of protein location in cell | 1.872845e-3 |
GO:0034442 | regulation of lipoprotein oxidation | 1.922894e-3 |
GO:0048936 | peripheral nervous system neuron axonogenesis | 1.934188e-3 |
GO:0006844 | acyl carnitine transport | 1.934188e-3 |
GO:0015931 | nucleobase-containing compound transport | 1.962533e-3 |
GO:0022027 | interkinetic nuclear migration | 1.974137e-3 |
GO:0002347 | response to tumor cell | 1.984416e-3 |
GO:0070375 | BMK cascade | 2.025683e-3 |
GO:0006086 | acetyl-CoA biosynthetic process from pyruvate | 2.025683e-3 |
GO:0034551 | mitochondrial respiratory chain complex III assembly | 2.087790e-3 |
GO:0032057 | negative regulation of translational initiation in response to stress | 2.087790e-3 |
GO:0060690 | epithelial cell differentiation involved in salivary gland development | 2.269717e-3 |
GO:0034372 | very-low-density lipoprotein particle remodeling | 2.360537e-3 |
GO:0051457 | maintenance of protein location in nucleus | 2.370092e-3 |
GO:0007529 | establishment of synaptic specificity at neuromuscular junction | 2.468664e-3 |
GO:0050746 | regulation of lipoprotein metabolic process | 2.558978e-3 |
GO:0002701 | negative regulation of production of molecular mediator of immune response | 2.837476e-3 |
GO:0043558 | regulation of translational initiation in response to stress | 2.900891e-3 |
GO:0071173 | spindle assembly checkpoint | 2.916842e-3 |
GO:0006288 | base-excision repair, DNA ligation | 2.953576e-3 |
GO:0032816 | positive regulation of natural killer cell activation | 2.961055e-3 |
GO:0043046 | DNA methylation involved in gamete generation | 3.006335e-3 |
GO:0050925 | negative regulation of negative chemotaxis | 3.040637e-3 |
GO:0018364 | peptidyl-glutamine methylation | 3.042097e-3 |
GO:0032513 | negative regulation of protein phosphatase type 2B activity | 3.042097e-3 |
GO:0071882 | activation of phospholipase C activity by adrenergic receptor signaling pathway | 3.268823e-3 |
GO:0071881 | inhibition of adenylate cyclase activity by adrenergic receptor signaling pathway | 3.268823e-3 |
GO:0042851 | L-alanine metabolic process | 3.268823e-3 |
GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I | 3.344822e-3 |
GO:0007493 | endodermal cell fate determination | 3.344822e-3 |
GO:0051651 | maintenance of location in cell | 3.524995e-3 |
GO:0050658 | RNA transport | 3.604731e-3 |
GO:0045954 | positive regulation of natural killer cell mediated cytotoxicity | 3.632322e-3 |
GO:0006403 | RNA localization | 3.650849e-3 |
GO:0072240 | metanephric DCT cell differentiation | 3.658052e-3 |
GO:0072227 | metanephric macula densa development | 3.658052e-3 |
GO:0006172 | ADP biosynthetic process | 3.658052e-3 |
GO:0018210 | peptidyl-threonine modification | 3.665030e-3 |
GO:0045623 | negative regulation of T-helper cell differentiation | 3.677762e-3 |
GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly | 3.710544e-3 |
GO:0002175 | protein localization to paranode region of axon | 3.710544e-3 |
GO:0042428 | serotonin metabolic process | 3.829075e-3 |
GO:0048477 | oogenesis | 3.920524e-3 |
GO:0046498 | S-adenosylhomocysteine metabolic process | 3.934145e-3 |
GO:0016578 | histone deubiquitination | 3.934145e-3 |
GO:0051028 | mRNA transport | 3.957969e-3 |
GO:0031629 | synaptic vesicle fusion to presynaptic membrane | 4.093861e-3 |
GO:0051684 | maintenance of Golgi location | 4.093861e-3 |
GO:0030150 | protein import into mitochondrial matrix | 4.093861e-3 |
GO:0007140 | male meiosis | 4.128536e-3 |
GO:0040015 | negative regulation of multicellular organism growth | 4.144522e-3 |
GO:0046636 | negative regulation of alpha-beta T cell activation | 4.179624e-3 |
GO:0035617 | stress granule disassembly | 4.274939e-3 |
GO:0035419 | activation of MAPK activity involved in innate immune response | 4.274939e-3 |
GO:0002541 | activation of plasma proteins involved in acute inflammatory response | 4.274939e-3 |
GO:0002693 | positive regulation of cellular extravasation | 4.274939e-3 |
GO:0050691 | regulation of defense response to virus by host | 4.290940e-3 |
GO:0006085 | acetyl-CoA biosynthetic process | 4.341231e-3 |
GO:0030240 | skeletal muscle thin filament assembly | 4.417305e-3 |
GO:0009595 | detection of biotic stimulus | 4.484634e-3 |
GO:0046639 | negative regulation of alpha-beta T cell differentiation | 4.521713e-3 |
GO:0035024 | negative regulation of Rho protein signal transduction | 4.521713e-3 |
GO:0019228 | regulation of action potential in neuron | 4.549986e-3 |
GO:2000779 | regulation of double-strand break repair | 4.550280e-3 |
GO:0035385 | Roundabout signaling pathway | 4.939284e-3 |
GO:0000083 | regulation of transcription involved in G1/S phase of mitotic cell cycle | 4.939284e-3 |
GO:0032849 | positive regulation of cellular pH reduction | 4.939284e-3 |
GO:0042089 | cytokine biosynthetic process | 5.025777e-3 |
GO:0030073 | insulin secretion | 5.040014e-3 |
GO:0010880 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | 5.045692e-3 |
GO:0032763 | regulation of mast cell cytokine production | 5.080027e-3 |
GO:0071174 | mitotic cell cycle spindle checkpoint | 5.107377e-3 |
GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway | 5.116146e-3 |
GO:0009597 | detection of virus | 5.116146e-3 |
GO:0032804 | negative regulation of low-density lipoprotein particle receptor catabolic process | 5.370888e-3 |
GO:0030091 | protein repair | 5.386900e-3 |
GO:0034227 | tRNA thio-modification | 5.611383e-3 |
GO:0090208 | positive regulation of triglyceride metabolic process | 5.643199e-3 |
GO:0010388 | cullin deneddylation | 5.791225e-3 |
GO:0019585 | glucuronate metabolic process | 5.826246e-3 |
GO:0034349 | glial cell apoptosis | 5.891735e-3 |
GO:0006863 | purine base transport | 5.893798e-3 |
GO:0006996 | organelle organization | 5.914976e-3 |
GO:0042930 | enterobactin transport | 5.969685e-3 |
GO:0045814 | negative regulation of gene expression, epigenetic | 5.983710e-3 |
GO:0032479 | regulation of type I interferon production | 6.209413e-3 |
GO:0042092 | type 2 immune response | 6.585837e-3 |
GO:0045217 | cell-cell junction maintenance | 6.585837e-3 |
GO:0018107 | peptidyl-threonine phosphorylation | 6.638121e-3 |
GO:0003071 | renal system process involved in regulation of systemic arterial blood pressure | 6.664060e-3 |
GO:0032803 | regulation of low-density lipoprotein particle receptor catabolic process | 6.752080e-3 |
GO:0045950 | negative regulation of mitotic recombination | 6.798010e-3 |
GO:0009051 | pentose-phosphate shunt, oxidative branch | 6.798010e-3 |
GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator | 6.838892e-3 |
GO:0034370 | triglyceride-rich lipoprotein particle remodeling | 6.856009e-3 |
GO:0033522 | histone H2A ubiquitination | 7.009055e-3 |
GO:0015986 | ATP synthesis coupled proton transport | 7.081065e-3 |
GO:2000515 | negative regulation of CD4-positive, alpha-beta T cell activation | 7.481302e-3 |
GO:0016068 | type I hypersensitivity | 7.551340e-3 |
GO:0010610 | regulation of mRNA stability involved in response to stress | 7.551340e-3 |
GO:0002591 | positive regulation of antigen processing and presentation of peptide antigen via MHC class I | 7.551340e-3 |
GO:0071205 | protein localization to juxtaparanode region of axon | 7.586085e-3 |
GO:0046671 | negative regulation of retinal cell programmed cell death | 7.586085e-3 |
GO:0044091 | membrane biogenesis | 7.586085e-3 |
GO:0000085 | G2 phase of mitotic cell cycle | 7.586085e-3 |
GO:0065002 | intracellular protein transmembrane transport | 7.717292e-3 |
GO:0018916 | nitrobenzene metabolic process | 7.717292e-3 |
GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process | 7.734900e-3 |
GO:0046836 | glycolipid transport | 7.734900e-3 |
GO:0070349 | positive regulation of brown fat cell proliferation | 7.734900e-3 |
GO:0002003 | angiotensin maturation | 7.734900e-3 |
GO:0006481 | C-terminal protein methylation | 7.734900e-3 |
GO:0006415 | translational termination | 7.830448e-3 |
GO:0014866 | skeletal myofibril assembly | 8.072373e-3 |
GO:0007016 | cytoskeletal anchoring at plasma membrane | 8.149458e-3 |
GO:0002719 | negative regulation of cytokine production involved in immune response | 8.217142e-3 |
GO:0032512 | regulation of protein phosphatase type 2B activity | 8.254781e-3 |
GO:0007403 | glial cell fate determination | 8.254781e-3 |
GO:0002483 | antigen processing and presentation of endogenous peptide antigen | 8.420043e-3 |
GO:0043985 | histone H4-R3 methylation | 8.480720e-3 |
GO:0035093 | spermatogenesis, exchange of chromosomal proteins | 8.480720e-3 |
GO:0003349 | epicardium-derived cardiac endothelial cell differentiation | 8.480720e-3 |
GO:0032534 | regulation of microvillus assembly | 8.480720e-3 |
GO:0035886 | vascular smooth muscle cell differentiation | 8.699618e-3 |
GO:0044241 | lipid digestion | 8.806468e-3 |
GO:0006108 | malate metabolic process | 8.831528e-3 |
GO:0051645 | Golgi localization | 8.831528e-3 |
GO:0006729 | tetrahydrobiopterin biosynthetic process | 8.910215e-3 |
GO:0010950 | positive regulation of endopeptidase activity | 8.910215e-3 |
GO:0000090 | mitotic anaphase | 8.910215e-3 |
GO:0034261 | negative regulation of Ras GTPase activity | 9.035037e-3 |
GO:0071634 | regulation of transforming growth factor beta production | 9.110858e-3 |
GO:0032847 | regulation of cellular pH reduction | 9.474024e-3 |
GO:0032648 | regulation of interferon-beta production | 9.607919e-3 |
GO:0019067 | viral assembly, maturation, egress, and release | 9.843449e-3 |
GO:0072218 | metanephric ascending thin limb development | 9.874893e-3 |
GO:0072233 | metanephric thick ascending limb development | 9.874893e-3 |
GO:0061002 | negative regulation of dendritic spine morphogenesis | 9.874893e-3 |
GO:0006269 | DNA replication, synthesis of RNA primer | 9.874893e-3 |
GO:0010882 | regulation of cardiac muscle contraction by calcium ion signaling | 9.990411e-3 |
GO:0046697 | decidualization | 1.015217e-2 |
GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity | 1.032290e-2 |
GO:0006975 | DNA damage induced protein phosphorylation | 1.044209e-2 |
GO:0019430 | removal of superoxide radicals | 1.054331e-2 |
GO:0051891 | positive regulation of cardioblast differentiation | 1.055356e-2 |
GO:0051725 | protein de-ADP-ribosylation | 1.064110e-2 |
GO:0032927 | positive regulation of activin receptor signaling pathway | 1.064110e-2 |
GO:0000917 | barrier septum formation | 1.064110e-2 |
GO:0002489 | antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent | 1.064110e-2 |
GO:0000266 | mitochondrial fission | 1.077441e-2 |
GO:0045089 | positive regulation of innate immune response | 1.088159e-2 |
GO:0032400 | melanosome localization | 1.096684e-2 |
GO:0032825 | positive regulation of natural killer cell differentiation | 1.096684e-2 |
GO:0001953 | negative regulation of cell-matrix adhesion | 1.105992e-2 |
GO:0070837 | dehydroascorbic acid transport | 1.132915e-2 |
GO:0010901 | regulation of very-low-density lipoprotein particle remodeling | 1.140493e-2 |
GO:2000426 | negative regulation of apoptotic cell clearance | 1.171489e-2 |
GO:2000384 | negative regulation of ectoderm development | 1.270445e-2 |
GO:0000019 | regulation of mitotic recombination | 1.270445e-2 |
GO:0010232 | vascular transport | 1.270445e-2 |
GO:0055107 | Golgi to secretory granule transport | 1.273260e-2 |
GO:0019408 | dolichol biosynthetic process | 1.273260e-2 |
GO:0010996 | response to auditory stimulus | 1.273260e-2 |
GO:0010189 | vitamin E biosynthetic process | 1.273260e-2 |
GO:0015851 | nucleobase transport | 1.276504e-2 |
GO:0019918 | peptidyl-arginine methylation, to symmetrical-dimethyl arginine | 1.277054e-2 |
GO:0010761 | fibroblast migration | 1.278731e-2 |
GO:0060486 | Clara cell differentiation | 1.321343e-2 |
GO:0042775 | mitochondrial ATP synthesis coupled electron transport | 1.325101e-2 |
GO:0032401 | establishment of melanosome localization | 1.325101e-2 |
GO:0035246 | peptidyl-arginine N-methylation | 1.325101e-2 |
GO:0006266 | DNA ligation | 1.336566e-2 |
GO:0007094 | mitotic cell cycle spindle assembly checkpoint | 1.349389e-2 |
GO:0002331 | pre-B cell allelic exclusion | 1.379008e-2 |
GO:0002098 | tRNA wobble uridine modification | 1.379008e-2 |
GO:0008584 | male gonad development | 1.387009e-2 |
GO:0007007 | inner mitochondrial membrane organization | 1.387473e-2 |
GO:0051935 | glutamate uptake involved in synaptic transmission | 1.391848e-2 |
GO:0045357 | regulation of interferon-beta biosynthetic process | 1.391848e-2 |
GO:0032814 | regulation of natural killer cell activation | 1.402043e-2 |
GO:0032740 | positive regulation of interleukin-17 production | 1.434726e-2 |
GO:0034109 | homotypic cell-cell adhesion | 1.439583e-2 |
GO:0072553 | terminal button organization | 1.444257e-2 |
GO:0008616 | queuosine biosynthetic process | 1.444257e-2 |
GO:0008611 | ether lipid biosynthetic process | 1.444257e-2 |
GO:0007620 | copulation | 1.451384e-2 |
GO:0051567 | histone H3-K9 methylation | 1.473396e-2 |
GO:0042773 | ATP synthesis coupled electron transport | 1.481378e-2 |
GO:0035247 | peptidyl-arginine omega-N-methylation | 1.529100e-2 |
GO:0030071 | regulation of mitotic metaphase/anaphase transition | 1.552056e-2 |
GO:0090218 | positive regulation of lipid kinase activity | 1.555368e-2 |
GO:0042559 | pteridine-containing compound biosynthetic process | 1.555368e-2 |
GO:0003310 | pancreatic A cell differentiation | 1.563599e-2 |
GO:0008637 | apoptotic mitochondrial changes | 1.584588e-2 |
GO:0060464 | lung lobe formation | 1.596437e-2 |
GO:0060540 | diaphragm morphogenesis | 1.596437e-2 |
GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway | 1.596437e-2 |
GO:0006189 | 'de novo' IMP biosynthetic process | 1.596437e-2 |
GO:0010960 | magnesium ion homeostasis | 1.596437e-2 |
GO:0021836 | chemorepulsion involved in postnatal olfactory bulb interneuron migration | 1.597087e-2 |
GO:0001831 | trophectodermal cellular morphogenesis | 1.597087e-2 |
GO:0045617 | negative regulation of keratinocyte differentiation | 1.605329e-2 |
GO:0035640 | exploration behavior | 1.609770e-2 |
GO:0060689 | cell differentiation involved in salivary gland development | 1.611536e-2 |
GO:0072595 | maintenance of protein localization to organelle | 1.622515e-2 |
GO:0016458 | gene silencing | 1.628564e-2 |
GO:0018216 | peptidyl-arginine methylation | 1.633833e-2 |
GO:0009081 | branched chain family amino acid metabolic process | 1.658024e-2 |
GO:0015854 | guanine transport | 1.698672e-2 |
GO:0015853 | adenine transport | 1.698672e-2 |
GO:0035344 | hypoxanthine transport | 1.698672e-2 |
GO:0035364 | thymine transport | 1.698672e-2 |
GO:0014808 | release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | 1.698672e-2 |
GO:0002176 | male germ cell proliferation | 1.698672e-2 |
GO:0007321 | sperm displacement | 1.698672e-2 |
GO:0032728 | positive regulation of interferon-beta production | 1.701148e-2 |
GO:0051322 | anaphase | 1.725785e-2 |
GO:0046425 | regulation of JAK-STAT cascade | 1.726597e-2 |
GO:0032438 | melanosome organization | 1.772923e-2 |
GO:0006754 | ATP biosynthetic process | 1.797867e-2 |
GO:0006284 | base-excision repair | 1.804157e-2 |
GO:0051103 | DNA ligation involved in DNA repair | 1.806974e-2 |
GO:0072520 | seminiferous tubule development | 1.821625e-2 |
GO:0002865 | negative regulation of acute inflammatory response to antigenic stimulus | 1.821625e-2 |
GO:0048050 | post-embryonic eye morphogenesis | 1.823301e-2 |
GO:0060947 | cardiac vascular smooth muscle cell differentiation | 1.885142e-2 |
GO:0030866 | cortical actin cytoskeleton organization | 1.894592e-2 |
GO:0007320 | insemination | 1.913273e-2 |
GO:0045628 | regulation of T-helper 2 cell differentiation | 1.916214e-2 |
GO:0045900 | negative regulation of translational elongation | 1.921164e-2 |
GO:0060064 | Spemann organizer formation at the anterior end of the primitive streak | 1.921164e-2 |
GO:0042840 | D-glucuronate catabolic process | 1.921164e-2 |
GO:0032782 | bile acid secretion | 1.921164e-2 |
GO:0003096 | renal sodium ion transport | 1.921164e-2 |
GO:0070647 | protein modification by small protein conjugation or removal | 1.921799e-2 |
GO:0000279 | M phase | 1.927544e-2 |
GO:0051043 | regulation of membrane protein ectodomain proteolysis | 1.939392e-2 |
GO:0032515 | negative regulation of phosphoprotein phosphatase activity | 1.940281e-2 |
GO:0031343 | positive regulation of cell killing | 1.960568e-2 |
GO:0048247 | lymphocyte chemotaxis | 1.964285e-2 |
GO:0043153 | entrainment of circadian clock by photoperiod | 1.964829e-2 |
GO:0001825 | blastocyst formation | 1.979770e-2 |
GO:0048255 | mRNA stabilization | 1.981157e-2 |
GO:0030913 | paranodal junction assembly | 1.990208e-2 |
GO:0006777 | Mo-molybdopterin cofactor biosynthetic process | 1.993374e-2 |
GO:0048753 | pigment granule organization | 1.993774e-2 |
GO:0046426 | negative regulation of JAK-STAT cascade | 1.993774e-2 |
GO:0032481 | positive regulation of type I interferon production | 1.993774e-2 |
GO:0010896 | regulation of triglyceride catabolic process | 1.993774e-2 |
GO:0001508 | regulation of action potential | 2.005264e-2 |
GO:0060575 | intestinal epithelial cell differentiation | 2.006342e-2 |
GO:0051641 | cellular localization | 2.061602e-2 |
GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly | 2.068134e-2 |
GO:0046146 | tetrahydrobiopterin metabolic process | 2.071538e-2 |
GO:2000425 | regulation of apoptotic cell clearance | 2.071538e-2 |
GO:0045351 | type I interferon biosynthetic process | 2.071538e-2 |
GO:0042520 | positive regulation of tyrosine phosphorylation of Stat4 protein | 2.071538e-2 |
GO:0006306 | DNA methylation | 2.119832e-2 |
GO:0005981 | regulation of glycogen catabolic process | 2.148735e-2 |
GO:2000383 | regulation of ectoderm development | 2.150448e-2 |
GO:0060312 | regulation of blood vessel remodeling | 2.157254e-2 |
GO:0009145 | purine nucleoside triphosphate biosynthetic process | 2.207080e-2 |
GO:0000070 | mitotic sister chromatid segregation | 2.256389e-2 |
GO:0033194 | response to hydroperoxide | 2.286265e-2 |
GO:0009206 | purine ribonucleoside triphosphate biosynthetic process | 2.326071e-2 |
GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin | 2.342799e-2 |
GO:0043551 | regulation of phosphatidylinositol 3-kinase activity | 2.372090e-2 |
GO:0071593 | lymphocyte aggregation | 2.384752e-2 |
GO:0035928 | rRNA import into mitochondrion | 2.384752e-2 |
GO:0009648 | photoperiodism | 2.384752e-2 |
GO:0060168 | positive regulation of adenosine receptor signaling pathway | 2.435833e-2 |
GO:0060003 | copper ion export | 2.435833e-2 |
GO:0071206 | establishment of protein localization to juxtaparanode region of axon | 2.435833e-2 |
GO:0010273 | detoxification of copper ion | 2.435833e-2 |
GO:0047484 | regulation of response to osmotic stress | 2.435833e-2 |
GO:0015677 | copper ion import | 2.435833e-2 |
GO:0045210 | FasL biosynthetic process | 2.435833e-2 |
GO:0042178 | xenobiotic catabolic process | 2.440081e-2 |
GO:0006600 | creatine metabolic process | 2.440081e-2 |
GO:0042107 | cytokine metabolic process | 2.442778e-2 |
GO:0002839 | positive regulation of immune response to tumor cell | 2.471680e-2 |
GO:0043550 | regulation of lipid kinase activity | 2.514815e-2 |
GO:0032530 | regulation of microvillus organization | 2.517088e-2 |
GO:0009083 | branched chain family amino acid catabolic process | 2.531108e-2 |
GO:0048821 | erythrocyte development | 2.576612e-2 |
GO:0070207 | protein homotrimerization | 2.601952e-2 |
GO:0002090 | regulation of receptor internalization | 2.637517e-2 |
GO:0015867 | ATP transport | 2.638040e-2 |
GO:0009152 | purine ribonucleotide biosynthetic process | 2.657972e-2 |
GO:0009201 | ribonucleoside triphosphate biosynthetic process | 2.660750e-2 |
GO:0016045 | detection of bacterium | 2.690518e-2 |
GO:0035404 | histone-serine phosphorylation | 2.698618e-2 |
GO:0051890 | regulation of cardioblast differentiation | 2.704812e-2 |
GO:0070625 | zymogen granule exocytosis | 2.718305e-2 |
GO:0051661 | maintenance of centrosome location | 2.718305e-2 |
GO:0048697 | positive regulation of collateral sprouting in absence of injury | 2.718305e-2 |
GO:0035459 | cargo loading into vesicle | 2.718305e-2 |
GO:0002837 | regulation of immune response to tumor cell | 2.756311e-2 |
GO:0006801 | superoxide metabolic process | 2.758673e-2 |
GO:0050869 | negative regulation of B cell activation | 2.761449e-2 |
GO:0042159 | lipoprotein catabolic process | 2.768062e-2 |
GO:0060896 | neural plate pattern specification | 2.778880e-2 |
GO:0046477 | glycosylceramide catabolic process | 2.819152e-2 |
GO:0048840 | otolith development | 2.819152e-2 |
GO:0040016 | embryonic cleavage | 2.819152e-2 |
GO:0015820 | leucine transport | 2.819152e-2 |
GO:0006974 | response to DNA damage stimulus | 2.829648e-2 |
GO:0032988 | ribonucleoprotein complex disassembly | 2.858350e-2 |
GO:0034214 | protein hexamerization | 2.923074e-2 |
GO:0055014 | atrial cardiac muscle cell development | 2.923074e-2 |
GO:0042516 | regulation of tyrosine phosphorylation of Stat3 protein | 2.931070e-2 |
GO:0030212 | hyaluronan metabolic process | 2.935749e-2 |
GO:0000819 | sister chromatid segregation | 2.949391e-2 |
GO:0060547 | negative regulation of necrotic cell death | 2.958155e-2 |
GO:0018106 | peptidyl-histidine phosphorylation | 2.958155e-2 |
GO:0019985 | translesion synthesis | 2.958757e-2 |
GO:0006878 | cellular copper ion homeostasis | 2.967559e-2 |
GO:0045022 | early endosome to late endosome transport | 2.967559e-2 |
GO:0051135 | positive regulation of NK T cell activation | 2.992187e-2 |
GO:0051386 | regulation of nerve growth factor receptor signaling pathway | 3.015973e-2 |
GO:0035358 | regulation of peroxisome proliferator activated receptor signaling pathway | 3.053569e-2 |
GO:0033628 | regulation of cell adhesion mediated by integrin | 3.122132e-2 |
GO:0019438 | aromatic compound biosynthetic process | 3.122132e-2 |
GO:0051875 | pigment granule localization | 3.154938e-2 |
GO:0015669 | gas transport | 3.177425e-2 |
GO:2000729 | positive regulation of mesenchymal cell proliferation involved in ureter development | 3.196561e-2 |
GO:0042699 | follicle-stimulating hormone signaling pathway | 3.196561e-2 |
GO:0046359 | butyrate catabolic process | 3.223563e-2 |
GO:0034346 | positive regulation of type III interferon production | 3.223563e-2 |
GO:0046398 | UDP-glucuronate metabolic process | 3.223563e-2 |
GO:0050653 | chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process | 3.223563e-2 |
GO:0021858 | GABAergic neuron differentiation in basal ganglia | 3.223563e-2 |
GO:0033326 | cerebrospinal fluid secretion | 3.223563e-2 |
GO:0006552 | leucine catabolic process | 3.223563e-2 |
GO:0021703 | locus ceruleus development | 3.223563e-2 |
GO:0006260 | DNA replication | 3.261700e-2 |
GO:0050765 | negative regulation of phagocytosis | 3.267279e-2 |
GO:2000833 | positive regulation of steroid hormone secretion | 3.303981e-2 |
GO:0090150 | establishment of protein localization in membrane | 3.303981e-2 |
GO:0002691 | regulation of cellular extravasation | 3.303981e-2 |
GO:2000121 | regulation of removal of superoxide radicals | 3.307313e-2 |
GO:0048025 | negative regulation of nuclear mRNA splicing, via spliceosome | 3.307313e-2 |
GO:0009142 | nucleoside triphosphate biosynthetic process | 3.343495e-2 |
GO:0014889 | muscle atrophy | 3.344871e-2 |
GO:0033059 | cellular pigmentation | 3.365464e-2 |
GO:0090116 | C-5 methylation of cytosine | 3.369747e-2 |
GO:0060014 | granulosa cell differentiation | 3.369747e-2 |
GO:0048280 | vesicle fusion with Golgi apparatus | 3.369747e-2 |
GO:0070946 | neutrophil mediated killing of gram-positive bacterium | 3.387370e-2 |
GO:0015855 | pyrimidine base transport | 3.387370e-2 |
GO:0030320 | cellular monovalent inorganic anion homeostasis | 3.419800e-2 |
GO:0016486 | peptide hormone processing | 3.454922e-2 |
GO:0042509 | regulation of tyrosine phosphorylation of STAT protein | 3.530517e-2 |
GO:0007064 | mitotic sister chromatid cohesion | 3.533191e-2 |
GO:0030002 | cellular anion homeostasis | 3.569196e-2 |
GO:0002833 | positive regulation of response to biotic stimulus | 3.576335e-2 |
GO:0007618 | mating | 3.591631e-2 |
GO:0045879 | negative regulation of smoothened signaling pathway | 3.596121e-2 |
GO:0008334 | histone mRNA metabolic process | 3.599256e-2 |
GO:0003014 | renal system process | 3.605747e-2 |
GO:0045819 | positive regulation of glycogen catabolic process | 3.606279e-2 |
GO:0003348 | cardiac endothelial cell differentiation | 3.606279e-2 |
GO:0050923 | regulation of negative chemotaxis | 3.644628e-2 |
GO:0070100 | negative regulation of chemokine-mediated signaling pathway | 3.644628e-2 |
GO:0060061 | Spemann organizer formation | 3.664030e-2 |
GO:0014028 | notochord formation | 3.664030e-2 |
GO:0051488 | activation of anaphase-promoting complex activity | 3.676284e-2 |
GO:0034770 | histone H4-K20 methylation | 3.676284e-2 |
GO:0033129 | positive regulation of histone phosphorylation | 3.755132e-2 |
GO:0007144 | female meiosis I | 3.755132e-2 |